Exclusion Criteria:~* A current DSM-IV diagnosis of major depression~* Taken rivastigmine in the past~* A score
of > 5 on the Modified Hachinski Ischemic Scale (MHIS) Other protocol-defined inclusion/exclusion criteria may
apply~Other protocol-defined inclusion/exclusion criteria may apply~Extension Phase Eligibility
Criteria~Inclusion Criteria:~* Patients who have completed the Double-blind Treatment Phase on study
medication~Exclusion Criteria~* Patients who have any important protocol deviations until the completion of the
Double-blind Treatment Phase
